Filter
2653
Filtered Results: 2653
Text search:
World
Health
Organization
(WHO),
Department
of
Reproductive
Health
and
Research
Featured
Recommendations
181
New Publications
817
Language
Document type
No document type
1736
Studies & Reports
434
Guidelines
255
Manuals
88
Strategic & Response Plan
74
Fact sheets
31
Training Material
21
Situation Updates
8
Resource Platforms
2
Infographics
2
Brochures
1
App
1
Countries / Regions
India
117
Kenya
104
Global
88
Nigeria
84
Uganda
80
Nepal
70
South Africa
69
Ethiopia
60
Malawi
58
Sierra Leone
51
Zambia
51
Myanmar / Burma
51
Tanzania
50
Liberia
42
Ghana
40
Bangladesh
36
Rwanda
30
Philippines
28
Africa
28
Latin America and the Carribbean
26
Cambodia
22
Western and Central Europe
21
Lesotho
20
Botswana
19
Senegal
18
Asia
18
Zimbabwe
17
Indonesia
17
Ukraine
16
Namibia
16
Syria
15
Haiti
15
South–East Asia Region
15
Mozambique
14
Congo, Democratic Republic of
11
Brazil
11
Burkina Faso
9
Guinea
9
Russia
9
Benin
8
Cameroon
8
Pakistan
8
Eastern Europe
7
Eswatini/ Swaziland
7
East and Southern Africa
6
South Sudan
6
Albania
5
Western Pacific Region
5
Colombia
4
China
4
Venezuela
4
Germany
4
West and Central Africa
4
Paraguay
4
Sudan
4
Yemen
4
Mali
4
Tajikistan
3
Afghanistan
3
Middle East and North Africa
3
Southern Africa
3
Papua New Guinea
3
Sri Lanka
3
Georgia
3
Somalia
3
Timor Leste/ East Timor
2
Thailand
2
Turkey
2
Canada
2
Laos
2
Burundi
2
Peru
2
Jordan
2
North America
2
Lebanon
2
Vietnam
2
Moldova
2
Romania
2
Honduras
2
Mexico
1
Serbia
1
Gambia
1
Estonia
1
Kyrgyzstan
1
Armenia
1
Dominican Republic
1
Hungary
1
Ireland
1
Eastern Europe and Central Asia
1
Turkmenistan
1
Japan
1
Denmark
1
Maldives
1
Côte d’Ivoire / Ivory Coast
1
Egypt
1
Slovakia
1
Palestine
1
Poland
1
Angola
1
Chad
1
Bhutan
1
Iraq
1
Ecuador
1
Madagascar
1
Guatemala
1
Authors & Publishers
Publication Years
Category
Countries
1128
Women & Child Health
248
Clinical Guidelines
187
Key Resources
125
Public Health
118
Capacity Building
42
Pharmacy & Technologies
12
Toolboxes
HIV
316
Mental Health
189
COVID-19
96
TB
87
Planetary Health
83
Disability
75
Caregiver
72
NTDs
64
Global Health Education
57
Ebola & Marburg
43
Health Financing Toolbox
39
Refugee
38
AMR
38
Rapid Response
35
Conflict
34
NCDs
29
Zika
27
Pharmacy
26
Natural Hazards
20
Specific Hazards
5
Social Ethics
5
Polio
4
Malaria
1
Typhoon
1
Pharmaceutical regulators are at the forefront of ensuring that only safe and effective medicines are authorized and available in the market. This document builds on the recommendations in the above publication and has been prepared to specifically assist national medicines regulatory authorities to...
Responses to epidemics, emergencies and disasters raise many ethical issues for the people involved, including public health specialists and policy makers. This training manual provides material on ethical issues in research, surveillance and patient care in these difficult contexts.
This guidance is intended to be used by programme managers following the decision to introduce human papillomavirus (HPV) virological testing as a screening assay in their national cervical cancer prevention and control programme. The guidance includes a step-by-step process to be followed after the...
Bulletin of the World Health Organization Volume 93, Number 9, September 2015, 589-664
Adolescent girls and young women (AGYW) remain disproportionately affected by HIV in Eastern and Southern Africa (ESA), with 26 per cent of new infections attributed to this population. AGYW face many personal, social and structural barriers to access, uptake and use of traditional HIV prevention me...
This handbook is for health care providers involved in the care of girls and women who have been subjected to any form of female genital mutilation (FGM). This includes obstetricians and gynaecologists, surgeons, general medical practitioners, midwives, nurses and other country-specific health profe...
15 July 2021. This report describes the demographics, clinical presentation, clinical outcomes, and risk factors among people living with HIV (PLHIV) who have been hospitalized for suspected or confirmed COVID-19.
The specific objectives of the analysis were to:
describe the clinical char...
This recommendation is an update of one of the 49 recommendations that were published in the WHO recommendations on antenatal care for a positive pregnancy experience. The recommendation was developed initially using the standardized operating procedures described in the WHO handbook for guideline d...
Quality of care in fragile, conflict-affected and vulnerable settings: tools and resources compendium
recommended
This compendium represents a curated, pragmatic and non-prescriptive collection of tools and resources to support the implementation of interventions to improve quality of care in such contexts. Relevant tools and resources are listed under five areas: Ensuring access and basic infrastructure for qu...
Consolidated guidelines on the Use of Antiretroviral Drugs for Treating and Preventing HIV Infection
recommended
2nd edition. These guidelines provide guidance on the diagnosis of human immunodeficiency virus (HIV) infection, the use of antiretroviral (ARV) drugs for treating and preventing HIV infection and the care of people living with HIV. They are structured along the continuum of HIV testing, prevention,...
Selection and Use of Essential Medicines 2021
recommended
The 23rd meeting of the WHO Expert Committee on Selection and Use of Essential Medicines was coordinated from Geneva, Switzerland, and held virtually from 21 June to 2 July 2021. The Committee considered 88 applications proposing additions, changes and deletions of medicines, medicine classes and fo...
Report of the 23rd WHO Expert Committee on the selection and use of essential medicines
This executive summary reports the recommendations made by the Expert Committee for the 2021 update of the WHO Model List of Essential Medicines (EML) and the Model List of Essential Medicine for Children (EMLc)...
Skin-related neglected tropical diseases, or “skin NTDs”, are historically neglected because active case detection, individual case management, significant resources and intensive effort are required to control, eliminate and eradicate them. Integrated control and management of skin NTDs offers ...
These guidelines provide new and updated recommendations on the use of point-of-care testing in children under 18 months of age and point-of-care tests to monitor treatment in people living with HIV; the treatment monitoring algorithm; and timing of antiretroviral therapy (ART) among people living w...
Noncommunicable diseases (NCDs) – chief among them, cardiovascular diseases (heart disease and stroke), cancer, diabetes and chronic respiratory diseases – along with mental health, cause nearly three quarters of deaths in the world. Their drivers are social, environmental, commercial and geneti...
Validation of elimination of mother-to-child transmission, or vertical transmission, of HIV, syphilis and hepatitis B virus (HBV), is an attestation that a country has successfully met standard criteria for elimination, or for being at 1 of the 3 levels of achievement on the ‘Path to Elimination...
It is impossible to address the many complex needs of respiratory virus surveillance with a single surveillance system. Multiple systems, investigations and studies must each be fit-for-purpose to specific priority surveillance objectives, and only together can they provide essential information to ...
This Rapid Advice Guideline updates the Interim Guidance on the “Assessment of infants with microcephaly in the context of Zika virus” published in February 2016 (WHO/ZIKV/MOC/16.3). The recommendations provides guidance on the screening, clinical assessment, neuroimaging, laboratory investigati...
July 2019
Policy brief
HIV Treatment
